This study found that higher FIB and FDP level, lower ATIII activity, higher TAT, PIC, TM and t-PAIC, and the JAK2V617F gene mutation are associated with thrombosis in MPN patients. The gene discussed is TAT; the disease is myeloproliferative neoplasm.